Ventas Files 8-K on Feb 29 for Other Events and Exhibits

TL;DR

**Ventas filed a routine 8-K on Feb 29 for 'Other Events' and 'Exhibits', but the key details aren't in this snippet.**

AI Summary

Ventas, Inc. filed an 8-K on February 29, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, with the earliest event reported also on February 29, 2024. The company, a real estate investment trust (REIT) based in Chicago, IL, with IRS Employer Identification No. 61-1055020, did not disclose specific financial figures or major corporate actions in the provided excerpt.

Why It Matters

This 8-K filing signals that Ventas, Inc. has information deemed important enough to disclose to investors, potentially impacting future financial performance or strategic direction, even if the specific details are not yet public.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Exhibits' without specific negative disclosures in the provided text, indicating no immediate high risk.

Key Numbers

• 2024-02-29 — Date of Report (Earliest event reported date)
• 0000740260 — Central Index Key (CIK) (Unique identifier for Ventas, Inc.)
• 61-1055020 — IRS Employer Identification No. (Tax identification for Ventas, Inc.)
• 1-10989 — Commission File Number (SEC filing identifier for Ventas, Inc.)
• 877-483-6827 — Registrant's Telephone Number (Contact number for Ventas, Inc.)

Key Players & Entities

• Ventas, Inc. (company) — Registrant
• February 29, 2024 (date) — Date of Report and Earliest Event Reported
• Chicago, Illinois (company) — Principal Executive Offices location
• 61-1055020 (dollar_amount) — IRS Employer Identification No.
• 1-10989 (dollar_amount) — Commission File Number

FAQ

Key Financial Figures

• $0.25 — ge on which registered Common stock, $0.25 par value VTR New York Stock Exchan
• $650 million — iced a private offering in Canada of Cdn$650 million of 5.10% Senior Notes, Series J due 202
• $500 million — ada (including under Ventas Canada's Cdn$500 million unsecured term loan facility) and/or fo

Filing Documents

• tm247614d1_8k.htm (8-K) — 38KB
• tm247614d1_ex99-1.htm (EX-99.1) — 19KB
• 0001104659-24-029420.txt ( ) — 241KB
• vtr-20240229.xsd (EX-101.SCH) — 3KB
• vtr-20240229_lab.xml (EX-101.LAB) — 33KB
• vtr-20240229_pre.xml (EX-101.PRE) — 22KB
• tm247614d1_8k_htm.xml (XML) — 4KB

01. Other Events

Item 8.01. Other Events. Offering of Senior Notes in Canada On February 29, 2024, Ventas Canada Finance Limited ("Ventas Canada"), an indirect, wholly-owned subsidiary of Ventas, Inc. ("Ventas" or the "Company"), launched and priced a private offering in Canada of Cdn$650 million of 5.10% Senior Notes, Series J due 2029 (the "Notes"). The sale of the Notes is expected to close on March 5, 2024, subject to satisfaction of customary closing conditions. The Notes will be guaranteed, on a senior unsecured basis, by the Company. Ventas Canada expects to use the net proceeds from the offering to repay existing indebtedness incurred by Ventas Canada (including under Ventas Canada's Cdn$500 million unsecured term loan facility) and/or for general corporate purposes, which may include acquisitions of, or investments in, additional properties and business. A copy of the press release issued by the Company regarding the pricing of the Notes is attached hereto as Exhibit 99.1. The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. Forward-Looking This Form 8-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of words such as "assume," "may," "will," "project," "expect," "believe," "inte

Forward-looking statements are based on management's

Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled "Cautionary Statements — Summary Risk Factors," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2023. 2 Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments of properties, including our ownership of the properties included in our equitized loan portfolio; (b) our exposure and the exposure of our tenants, managers and borrowers to complex healthcare and other regulation, including evolving laws and regulations regarding data privacy and cybersecurity and environmental matters, and the challenges and expense associated with complying with such regulation; (c) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, managers or borrowers to increased operating costs, uninsured liabilities, fines o

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit Number Description 99.1 Pricing Press Release dated February 29, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL). 4

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VENTAS, INC. Date: February 29, 2024 By: /s/ Carey S. Roberts Name: Carey S. Roberts Title: Executive Vice President, General Counsel and Ethics & Compliance Officer 5

View Full Filing

View this 8-K filing on SEC EDGAR